Literature DB >> 22378914

Performance of the Abbott RealTime and Roche Cobas TaqMan hepatitis C virus (HCV) assays for quantification of HCV genotypes.

Heidi LaRue1, Lisa Rigali, Joan-Miquel Balada-Llasat, Preeti Pancholi.   

Abstract

We evaluated the Abbott RealTime (ART) and Roche Cobas TaqMan Hepatitis C virus (HCV) viral load assays for quantification of HCV genotypes in patient specimens. The ART HCV assay was a more sensitive and precise tool for accurate HCV viral load quantification across the HCV genotypes tested, especially genotype 1b.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22378914      PMCID： PMC3347146          DOI： 10.1128/JCM.06723-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  23 in total

1.  Development of a second version of the Cobas AmpliPrep/Cobas TaqMan hepatitis C virus quantitative test with improved genotype inclusivity.

Authors:  Johannes Vermehren; Giuseppe Colucci; Peter Gohl; Nabila Hamdi; Ahmed Ihab Abdelaziz; Ursula Karey; Diana Thamke; Heike Zitzer; Stefan Zeuzem; Christoph Sarrazin
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

2.  Consistency of quantitation of HCV genotype 4 from egypt across three HCV-RNA amplification assays.

Authors:  Fathia Zaky El Sharkawi; Michael Chudy; Kay-Martin Hanschmann; Julia Kress; C Micha Nübling
Journal:  J Med Virol       Date:  2008-12       Impact factor: 2.327

3.  EASL Clinical Practice Guidelines: management of hepatitis C virus infection.

Authors: 
Journal:  J Hepatol       Date:  2011-03-01       Impact factor: 25.083

4.  Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium.

Authors: 
Journal:  J Viral Hepat       Date:  1999-01       Impact factor: 3.728

5.  Multilaboratory comparison of hepatitis C virus viral load assays.

Authors:  A M Caliendo; A Valsamakis; Y Zhou; B Yen-Lieberman; J Andersen; S Young; A Ferreira-Gonzalez; G J Tsongalis; R Pyles; J W Bremer; N S Lurain
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

6.  Evaluation of the analytical performance of the new Abbott RealTime RT-PCRs for the quantitative detection of HCV and HIV-1 RNA.

Authors:  M Schutten; E Fries; C Burghoorn-Maas; H G M Niesters
Journal:  J Clin Virol       Date:  2007-09-04       Impact factor: 3.168

Review 7.  Hepatitis C virus: virology, diagnosis and management of antiviral therapy.

Authors:  Stéphane Chevaliez; Jean-Michel Pawlotsky
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

8.  Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method.

Authors:  Stéphane Chevaliez; Magali Bouvier-Alias; Rozenn Brillet; Jean-Michel Pawlotsky
Journal:  Hepatology       Date:  2007-07       Impact factor: 17.425

9.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

10.  An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases.

Authors:  Marc G Ghany; David R Nelson; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2011-09-26       Impact factor: 17.425
View more
  6 in total

1.  Variation analysis of six HCV viral load assays using low viremic HCV samples in the range of the clinical decision points for HCV protease inhibitors.

Authors:  F Wiesmann; G Naeth; C Sarrazin; A Berger; R Kaiser; R Ehret; H Knechten; P Braun
Journal:  Med Microbiol Immunol       Date:  2014-11-15       Impact factor: 3.402

2.  European Multicenter Study on Analytical Performance of DxN Veris System HCV Assay.

Authors:  Patrick Braun; Rafael Delgado; Monica Drago; Diana Fanti; Hervé Fleury; Maria Rita Gismondo; Jörg Hofmann; Jacques Izopet; Sebastian Kühn; Alessandra Lombardi; Maria Angeles Marcos; Karine Sauné; Siobhan O'Shea; Alfredo Pérez-Rivilla; John Ramble; Pascale Trimoulet; Jordi Vila; Duncan Whittaker; Alain Artus; Daniel W Rhodes
Journal:  J Clin Microbiol       Date:  2017-02-01       Impact factor: 5.948

3.  Utility of hepatitis C viral load monitoring on direct-acting antiviral therapy.

Authors:  Sreetha Sidharthan; Anita Kohli; Zayani Sims; Amy Nelson; Anu Osinusi; Henry Masur; Shyam Kottilil
Journal:  Clin Infect Dis       Date:  2015-03-02       Impact factor: 9.079

4.  Real-Time PCR Assays for the Quantification of HCV RNA: Concordance, Discrepancies and Implications for Response Guided Therapy.

Authors:  Robert Strassl; Karoline Rutter; Albert Friedrich Stättermayer; Sandra Beinhardt; Michael Kammer; Harald Hofer; Peter Ferenci; Theresia Popow-Kraupp
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

5.  Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response.

Authors:  Gavin Cloherty; Stephane Chevaliez; Christoph Sarrazin; Christine Herman; Vera Holzmayer; George Dawson; Benjamin Maasoumy; Johannes Vermehren; Heiner Wedemeyer; Jordan J Feld; Jean-Michel Pawlotsky
Journal:  Sci Rep       Date:  2016-10-20       Impact factor: 4.379

6.  Diverse HCV Strains And HIV URFS Identified Amongst People Who Inject Drugs In India.

Authors:  Mary A Rodgers; Selvamurthi Gomathi; Ana Vallari; Shanmugam Saravanan; Gregory M Lucas; Shruti Mehta; Sunil S Solomon; Gavin A Cloherty
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.